Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 12, 2016
Eurofins Genomics has announced the U.S. launch of its EXTREmer oligonucleotides, extremely long oligos that are developed using high-fidelity synthesis chemistry on the company's new DNA synthesis platform. Designed for synthetic biology, next-...
read more
Wednesday, December 07, 2016
Recipharm is entering into collaboration with Laccure AB for the commercial manufacture and delivery of Laccure® Pessary.
read more
Wednesday, December 07, 2016
Albumedix has entered into a collaborative research agreement with the New York University (NYU) School of Medicine. The collaboration will explore the potential of novel applications of Albumedix’s albumin-based drug delivery platform, Veltis®, to ...
read more
Wednesday, December 07, 2016
Biothera Pharmaceuticals has announced an expansion of its research collaboration with Merck (known as MSD outside the United States and Canada) to include a Phase 2 clinical study investigating Biothera’s Imprime PGG in combination with KEYTRUDA® (...
read more
Wednesday, December 07, 2016
Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport.
read more
Wednesday, December 07, 2016
Idifarma has acquired a Bosch GKF-702 capsule filling machine, capable of manufacturing from 3,000 to 42,000 capsules per hour. The new equipment will be installed at the CDMO’s EU-GMP approved plant in Pamplona, Spain, in early 2017.
read more
Wednesday, December 07, 2016
MilliporeSigma will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor's antibody fragment used for the primary treatment of ischemic stroke.
read more
Monday, December 05, 2016
IT experts of TÜV Süd, a German industrial testing organization, have certified the new data processing center at Vetter's headquarters in Ravensburg, Germany. According to TÜV Süd, the pharmaceutical service provider has fulfilled all criteria ...
read more
Friday, December 02, 2016
Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced that Prasad Raje, Ph.D., has been appointed President and Chief Executive Officer, succeeding James M. Matthew, who served as interim President and Chief ...
read more
Wednesday, November 30, 2016
Supply Chain Wizard, a full-service global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs – is co-hosting the Pharma CMO Summit on December 12, 2016 at the ...
read more
Wednesday, November 30, 2016
MilliporeSigma has entered into a set of agreements with Evotec AG, whereby Evotec AG will provide screening services for MilliporeSigma's collection of genetic reagents such as CRISPR and shRNA libraries. Combining access to these libraries with ...
read more
Wednesday, November 30, 2016
Center Point Clinical Services, creator of the Clinical Trial Research Pharmacist (CTRP®) solution, has announced the launch of the world's first site-less, technology CRO. The Site-less CRO model is designed to support the evolving world of ...
read more
Wednesday, November 30, 2016
Aptuit announced that it has successfully completed the expansion of their lead-like screening library. An additional 150,000 novel compounds have increased the Screening Collection to over 400,000.
read more
Tuesday, November 29, 2016
Patheon has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltd.,...
read more
Tuesday, November 29, 2016
Vigene Biosciences, a biotechnology company focused on viral vector production and development, has entered into a definitive agreement to acquire the assets of Omnia Biologics, Inc. (Omnia), including Omnia's cGMP facility and equipment. The ...
read more